Allogene Therapeutics, Inc.
Overview
Allogene Therapeutics, Inc. is a biotechnology company specializing in the development of allogeneic CAR T-cell therapies for cancer treatment. The company is committed to delivering safe, efficient, and accessible therapies to patients with cancer and aims to transform the CAR T landscape.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Allogene Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Allogene Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.